Cellebrite DI Ltd. (CLBT), a provider of digital intelligence and investigative software used by law enforcement, defense, and intelligence agencies, saw its shares drop sharply on Thursday. As of mid-morning trading, the stock was down 36.72% at $9.65, compared with the prior session's closing price of $15.25. The decline came after the company reported mixed quarterly results, lowered its full-year revenue outlook, and announced a leadership change.
The most immediate driver behind the decline was the company's quarterly report. CLBT posted second-quarter fiscal 2026 revenue of $131.1 million, up 15.7% from $113.3 million a year earlier, but slightly below consensus estimates near $131.9 million. Non-GAAP earnings per share came in at $0.11, while reported net income fell to $6.37 million from $19.48 million in the prior-year quarter as operating expenses rose.
More importantly, management lowered its fiscal 2026 revenue guidance to a range of $555 million to $561 million, down from the prior outlook of $565 million to $571 million. The company also guided third-quarter revenue to $145 million to $148 million, below the roughly $150 million analysts had anticipated. Although adjusted EBITDA guidance was modestly raised, the softer revenue trajectory dominated the market reaction.
Compounding the earnings-driven move, CLBT announced that Shiven Ramji has succeeded Thomas E. Hogan as chief executive officer, effective August 13. Ramji joined the company in May as President of Products and Technology. Leadership changes during a period of tempered growth expectations can amplify selling pressure, as investors reassess execution risk and the pace of strategic initiatives such as the company's Inseyets expansion.
The sell-off was not part of a broader technology or software decline. At the same time, major equity benchmarks were trading higher, with large-cap technology indices up roughly 0.6% to 0.9%. That divergence underscores that the move in CLBT was driven primarily by company-specific news rather than macro conditions.
Trading activity was elevated, with heavy volume in the opening session following an already sharp pre-market reaction. The gap lower pushed shares decisively below their recent trading range of roughly $14 to $16, marking a significant technical breakdown for the stock.
Looking ahead, investors will monitor how the new CEO executes the company's product and expansion strategy, particularly around Inseyets deployments and subscription growth. The next major company catalyst will be the third-quarter fiscal 2026 earnings release, along with any updates on government and public-sector demand. Risks include continued pressure on revenue growth, integration of the leadership transition, and any further changes to guidance. The stock's sharp repricing suggests the market will require evidence of stabilizing revenue momentum before confidence returns.
Tickeron's Trending AI Robots page highlights a curated selection of AI-powered trading bots that are performing strongly under current market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, with strategies that vary by approach, timeframe, performance metrics, and traded symbols. Explore the Trending AI Robots section to see which automated strategies are adapting to today's market environment.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
CLBT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 31 of 34 cases where CLBT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CLBT's RSI Oscillator exited the oversold zone, 24 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for CLBT just turned positive on August 31, 2026. Looking at past instances where CLBT's MACD turned positive, the stock continued to rise in 41 of 54 cases over the following month. The odds of a continued upward trend are 76%.
Following a +8.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLBT advanced for three days, in 228 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Momentum Indicator moved below the 0 level on September 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CLBT as a result. In 66 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
CLBT moved below its 50-day moving average on August 13, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CLBT crossed bearishly below the 50-day moving average on August 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLBT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The Aroon Indicator for CLBT entered a downward trend on August 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 54 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.247) is normal, around the industry mean (22.181). P/E Ratio (48.826) is within average values for comparable stocks, (120.106). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.993). CLBT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (5.488) is also within normal values, averaging (109.949).
The Tickeron SMR rating for this company is 63 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. CLBT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 93 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLBT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerCommunications